{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T08:43:13Z","timestamp":1788424993246,"version":"build-2803163510"},"reference-count":45,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Institute for Personalized and Translational Medicine, Ariel University, Israel","award":["RA1600000120"],"award-info":[{"award-number":["RA1600000120"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Interferon (IFN) signaling resulting from external or internal inflammatory processes initiates the rapid release of cytokines and chemokines to target viral or bacterial invasion, as well as cancer and other diseases. Prolonged exposure to IFNs, or the overexpression of other cytokines, leads to immune exhaustion, enhancing inflammation and leading to the persistence of infection and promotion of disease. Hence, to control and stabilize an excessive immune response, approaches for the management of inflammation are required. The potential use of peptides as anti-inflammatory agents has been previously demonstrated. Our team discovered, and previously published, a 9-amino-acid cyclic peptide named ALOS4 which exhibits anti-cancer properties in vivo and in vitro. We suggested that the anti-cancer effect of ALOS4 arises from interaction with the immune system, possibly through the modulation of inflammatory processes. Here, we show that treatment with ALOS4 decreases basal cytokine levels in mice with chronic inflammation and prolongs the lifespan of mice with acute systemic inflammation induced by irradiation. We also show that pretreatment with ALOS4 reduces the expression of IFN alpha, IFN lambda, and selected interferon-response genes triggered by polyinosinic-polycytidylic acid (Poly I:C), a synthetic analog of viral double-stranded RNA, while upregulating the expression of other genes with antiviral activity. Hence, we conclude that ALOS4 does not prevent IFN signaling, but rather supports the antiviral response by upregulating the expression of interferon-response genes in an interferon-independent manner.<\/jats:p>","DOI":"10.3390\/ijms23137248","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T22:43:28Z","timestamp":1656542608000},"page":"7248","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeted Modulation of Interferon Response-Related Genes with IFN-Alpha\/Lambda Inhibition"],"prefix":"10.3390","volume":"23","author":[{"given":"Debpali","family":"Sur","sequence":"first","affiliation":[{"name":"Department of Molecular Biology, Faculty of Natural Sciences, Ariel University, Ariel 4070000, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Leonova","sequence":"additional","affiliation":[{"name":"Department of Cell Stress Biology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bar","family":"Levi","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, Faculty of Natural Sciences, Ariel University, Ariel 4070000, Israel"},{"name":"Institute for Personalized and Translational Medicine, Ariel University, Ariel 4070000, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shany Ivon","family":"Markowitz","sequence":"additional","affiliation":[{"name":"Institute for Personalized and Translational Medicine, Ariel University, Ariel 4070000, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raichel","family":"Cohen-Harazi","sequence":"additional","affiliation":[{"name":"Institute for Personalized and Translational Medicine, Ariel University, Ariel 4070000, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya","family":"Gitlin","sequence":"additional","affiliation":[{"name":"Department of Cell Stress Biology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Gurova","sequence":"additional","affiliation":[{"name":"Department of Cell Stress Biology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Gudkov","sequence":"additional","affiliation":[{"name":"Department of Cell Stress Biology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Pinhasov","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, Faculty of Natural Sciences, Ariel University, Ariel 4070000, Israel"},{"name":"Institute for Personalized and Translational Medicine, Ariel University, Ariel 4070000, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Koman","sequence":"additional","affiliation":[{"name":"Institute for Personalized and Translational Medicine, Ariel University, Ariel 4070000, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8326-5535","authenticated-orcid":false,"given":"Elimelech","family":"Nesher","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, Faculty of Natural Sciences, Ariel University, Ariel 4070000, Israel"},{"name":"Institute for Personalized and Translational Medicine, Ariel University, Ariel 4070000, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: Immunity, inflammation and intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e12970","DOI":"10.1111\/sji.12970","article-title":"An inflammation classification system using cytokine parameters","volume":"93","author":"Roe","year":"2021","journal-title":"Scand. J. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"7204","DOI":"10.18632\/oncotarget.23208","article-title":"Inflammatory responses and inflammation-associated diseases in organs","volume":"9","author":"Chen","year":"2018","journal-title":"Oncotarget"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1161\/CIRCRESAHA.118.314669","article-title":"Inflammation and Its Role in Regeneration and Repair","volume":"124","author":"Cooke","year":"2019","journal-title":"Circ. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e20190295","DOI":"10.1084\/jem.20190295","article-title":"Type III interferons: Balancing tissue tolerance and resistance to pathogen invasion","volume":"217","author":"Broggi","year":"2020","journal-title":"J. Exp. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12974-021-02370-1","article-title":"Immune response and pathogen invasion at the choroid plexus in the onset of cerebral toxoplasmosis","volume":"19","author":"Figueiredo","year":"2022","journal-title":"J. Neuroinflamm."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/s41418-021-00866-0","article-title":"Fatal cytokine release syndrome by an aberrant FLIP\/STAT3 axis","volume":"29","author":"Musiu","year":"2022","journal-title":"Cell Death Differ."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/jmv.27405","article-title":"Role of toll-like receptors in modulation of cytokine storm signaling in SARS-CoV-2-induced COVID-19","volume":"94","author":"Manik","year":"2022","journal-title":"J. Med. Virol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s41232-020-00146-3","article-title":"How COVID-19 induces cytokine storm with high mortality","volume":"40","author":"Hojyo","year":"2020","journal-title":"Inflamm. Regen."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Ramatillah, D.L., Gan, S.H., Pratiwy, I., Syed Sulaiman, S.A., Jaber, A.A.S., Jusnita, N., Lukas, S., and Abu Bakar, U. (2022). Impact of cytokine storm on severity of COVID-19 disease in a private hospital in West Jakarta prior to vaccination. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0262438"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/nsr\/nwaa041","article-title":"Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients","volume":"7","author":"Zhou","year":"2020","journal-title":"Natl. Sci. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Bayarsaikhan, G., Bayarsaikhan, D., Lee, J., and Lee, B. (2022). Targeting Scavenger Receptors in Inflammatory Disorders and Oxidative Stress. Antioxidants, 11.","DOI":"10.3390\/antiox11050936"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","article-title":"The pathogenesis and treatment of the \u2018Cytokine Storm\u2019 in COVID-19","volume":"80","author":"Ye","year":"2020","journal-title":"J. Infect."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Wicherska-Pawlowska, K., Wrobel, T., and Rybka, J. (2021). Toll-Like Receptors (TLRs), NOD-Like Receptors (NLRs), and RIG-I-Like Receptors (RLRs) in Innate Immunity. TLRs, NLRs, and RLRs Ligands as Immunotherapeutic Agents for Hematopoietic Diseases. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222413397"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"608645","DOI":"10.3389\/fimmu.2020.608645","article-title":"Importance of Type I and III Interferons at Respiratory and Intestinal Barrier Surfaces","volume":"11","author":"Stanifer","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.immuni.2019.03.025","article-title":"Shared and Distinct Functions of Type I and Type III Interferons","volume":"50","author":"Lazear","year":"2019","journal-title":"Immunity"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1038\/s41467-019-10970-y","article-title":"A molecular switch from STAT2-IRF9 to ISGF3 underlies interferon-induced gene transcription","volume":"10","author":"Platanitis","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Peluzzo, A.M., and Autieri, M.V. (2022). Challenging the Paradigm: Anti-Inflammatory Interleukins and Angiogenesis. Cells, 11.","DOI":"10.3390\/cells11030587"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"101277","DOI":"10.1016\/j.smim.2019.05.001","article-title":"Type I interferon signaling, regulation and gene stimulation in chronic virus infection","volume":"43","author":"Lukhele","year":"2019","journal-title":"Semin. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41584-021-00606-1","article-title":"Interferon lambda in inflammation and autoimmune rheumatic diseases","volume":"17","author":"Goel","year":"2021","journal-title":"Nat. Reviews. Rheumatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12016-020-08798-2","article-title":"Type I Interferons in the Pathogenesis and Treatment of Autoimmune Diseases","volume":"59","author":"Jiang","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/JLB.2MIR0817-342R","article-title":"Negative regulation of type I IFN signaling","volume":"103","author":"Arimoto","year":"2018","journal-title":"J. Leukoc. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"107781","DOI":"10.1016\/j.celrep.2020.107781","article-title":"The Leucine-Rich Repeat Region of CARMIL1 Regulates IL-1-Mediated ERK Activation, MMP Expression, and Collagen Degradation","volume":"31","author":"Wang","year":"2020","journal-title":"Cell Rep."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"La Manna, S., Di Natale, C., Florio, D., and Marasco, D. (2018). Peptides as Therapeutic Agents for Inflammatory-Related Diseases. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19092714"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"120637","DOI":"10.1016\/j.lfs.2022.120637","article-title":"Exploring bioactive peptides as potential therapeutic and biotechnology treasures: A contemporary perspective","volume":"301","author":"Patil","year":"2022","journal-title":"Life Sci."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Fu, T.K., Kuo, P.H., Lu, Y.C., Lin, H.N., Wang, L.H., Lin, Y.C., Kao, Y.C., Lai, H.M., and Chang, M.D. (2020). Cell Penetrating Peptide as a High Safety Anti-Inflammation Ingredient for Cosmetic Applications. Biomolecules, 10.","DOI":"10.3390\/biom10010101"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/jbm.a.37192","article-title":"Engineered synthetic cell penetrating peptide with intracellular anti-inflammatory bioactivity: An in vitro and in vivo study","volume":"109","author":"Lee","year":"2021","journal-title":"J. Biomed. Mater. Res. Part A"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"63549","DOI":"10.18632\/oncotarget.11363","article-title":"Novel synthetic cyclic integrin alphavbeta3 binding peptide ALOS4: Antitumor activity in mouse melanoma models","volume":"7","author":"Yacobovich","year":"2016","journal-title":"Oncotarget"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"757","DOI":"10.18632\/oncotarget.12748","article-title":"Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma","volume":"8","author":"Redko","year":"2017","journal-title":"Oncotarget"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Levi, B., Yacobovich, S., Kirby, M., Becker, M., Agranyoni, O., Redko, B., Gellerman, G., Pinhasov, A., Koman, I., and Nesher, E. (2021). Anti-Cancer Effects of Cyclic Peptide ALOS4 in a Human Melanoma Mouse Model. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22179579"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e30842","DOI":"10.7554\/eLife.30842","article-title":"TRAIN (Transcription of Repeats Activates INterferon) in response to chromatin destabilization induced by small molecules in mammalian cells","volume":"7","author":"Leonova","year":"2018","journal-title":"eLife"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e0282921","DOI":"10.1128\/mBio.02829-21","article-title":"Human IFIT3 Protein Induces Interferon Signaling and Inhibits Adenovirus Immediate Early Gene Expression","volume":"12","author":"Chikhalya","year":"2021","journal-title":"mBio"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Ashley, C.L., Abendroth, A., McSharry, B.P., and Slobedman, B. (2019). Interferon-Independent Upregulation of Interferon-Stimulated Genes during Human Cytomegalovirus Infection is Dependent on IRF3 Expression. Viruses, 11.","DOI":"10.3390\/v11030246"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"605673","DOI":"10.3389\/fimmu.2020.605673","article-title":"Shared and Unique Features of Human Interferon-Beta and Interferon-Alpha Subtypes","volume":"11","author":"Wittling","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"9901","DOI":"10.18632\/aging.102440","article-title":"Innate sensitivity to stress facilitates inflammation, alters metabolism and shortens lifespan in a mouse model of social hierarchy","volume":"11","author":"Bairachnaya","year":"2019","journal-title":"Aging"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3147671","DOI":"10.1155\/2016\/3147671","article-title":"Actions of Thyroid Hormone Analogues on Chemokines","volume":"2016","author":"Davis","year":"2016","journal-title":"J. Immunol. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"13911","DOI":"10.1128\/JVI.01894-13","article-title":"Type I interferon and NF-kappaB activation elicited by herpes simplex virus gH\/gL via alphavbeta3 integrin in epithelial and neuronal cell lines","volume":"87","author":"Gianni","year":"2013","journal-title":"J. Virol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Carlsen, L., and El-Deiry, W.S. (2021). Differential p53-Mediated Cellular Responses to DNA-Damaging Therapeutic Agents. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222111828"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.semradonc.2014.07.007","article-title":"Radiation and inflammation","volume":"25","author":"Schaue","year":"2015","journal-title":"Semin. Radiat. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1172\/JCI127458","article-title":"Type I IFN protects cancer cells from CD8+ T cell\u2013mediated cytotoxicity after radiation","volume":"129","author":"Chen","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev-pathol-031920-093932","article-title":"Opposing Roles of Type I Interferons in Cancer Immunity","volume":"16","author":"Boukhaled","year":"2021","journal-title":"Annu. Rev. Pathol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Musella, M., Galassi, C., Manduca, N., and Sistigu, A. (2021). The Yin and Yang of Type I IFNs in Cancer Promotion and Immune Activation. Biology, 10.","DOI":"10.3390\/biology10090856"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s12031-011-9544-0","article-title":"Comparative analysis of the behavioral and biomolecular parameters of four mouse strains","volume":"46","author":"Nesher","year":"2012","journal-title":"J. Mol. Neurosci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1096\/fj.04-3213fje","article-title":"p53 is a suppressor of inflammatory response in mice","volume":"19","author":"Komarova","year":"2005","journal-title":"FASEB J."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/13\/7248\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:40:44Z","timestamp":1760139644000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/13\/7248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":45,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["ijms23137248"],"URL":"https:\/\/doi.org\/10.3390\/ijms23137248","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,29]]}}}